Abstract
The development of rational, neurotransmitter-based, pharmacological treatments for Alzheimer’s disease (AD) is largely based on substantial cholinergic abnormalities. However, it now appears likely that the neocortical cholinergic deficit in AD can only explain a part of the entire clinical syndrome and that loss of glutamatergic cortical pyramidal neurones is as important.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ottersen, O.P., 1991, Excitatory amino acid antagonists (B.S. Meldrum, ed.), Blackwell Scientific Publications, Oxford, 14–38.
Francis, P.T., Sims, N.R., Procter, A.W. and Bowen, D.M., 1993, J. Neurochem. 60: 1589–l604.
Esiri, M, 1991, Psychiatry in the Elderly (R. Jacoby and C. Oppenheimer, eds.), Oxford University Press, Oxford, 113–147.
Esiri, M.M., Pearson, R.C.A., Steele, J.E., Bowen, D.M. and Powell, T.P.S., 1990, J. Neurol. Neurosurg. Psychiatry 53: 161–165.
Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A. and Katzman, R., 1991, Ann. Neurol. 30: 572–580.
Braak, H. and Braak, E., 1985, Acta Neuropathol. 68: 325–332.
Neary, D., Snowden, J.S., Mann, D.M., Bowen, D.M., Sims, N.R., Northen, B., Yates, P.O. and Davison, A.N., 1986, J. Neurol Neurosurg. Psychiatry 49: 229–231.
DeKosky, S.T. and Scheff, S.W., 1990, Ann. Neurol. 27: 457–464.
Terry, R.D., Masliah, D., Salman, N., Butters, R., DeTeresa, R., Hansen, L. and Katzman, R., 1990, Neurobiol. Aging 11: 266
Terry, R.D., Peck, A., DeTeresa, R., Schechter, R. and Houroupian, D.S., 1981, Ann. Neurol. 10: 184–192.
Cutler, N.R., Haxby, J.V., Duara, R., Grady, C.L., Kay, A.D., Kessler, R.M., Sundram, M. and Rapoport, S., 1985, Ann. Neurol. 18: 298–309.
Kisvarday, Z.F., Martin, K.A.C., Freund, T.F., Magloczky, Z., Whitteridge, D. and Somogyi, P., 1986, Exp. Brain Res. 64: 541–552.
Hyman, B.T., Van Hoesen, G.W. and Damasio, A.R., 1987, Ann. Neurol. 22: 37–40.
Kowall, N.W. and Beal, M.F., 1991, Ann. Neurol. 29: 162–167.
Kesslak, J.P., Nalcioglu, O. and Cotman, C.W., 1991, Neurology 41: 51–54.
Hyman, B.T., Van Hoesen, G.W. and Damasio, A.R., 1990, Neurology 40: 1721–1730.
McCormick, D.A. and Williamson, A., 1989, Proc. Natl. Acad. Sci. USA. 86: 8098–8102.
Chalmers, D.T., Dewar, D., Graham, D.I., Brooks, D.N. and McCulloch, J., 1990, Proc. Natl. Acad. Sci. USA. 87: 1352–1356.
Steele, J.E., Cross, A.J. and Bowen, D.M., 1992, Neurodegeneration 1: 225–230.
Procter, A.W., Stratmann, G.C., Francis, P.T., Lowe, S.L., Bertolucci, PH. F. and Bowen, D.M., 1991, J. Neurochem. 56: 299–310.
Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P. and Honore, T., 1990, Science 247: 571–574.
Germano, I.M., Pitts, L.H., Meldrum, B.S., Bartkowski, H.M. and Simon, R.P., 1987, Ann. Neurol. 22: 730–734.
Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R. E., 1992, J. Neurosci. 12: 376–389.
Bowen, D.M., Francis, P.T., Chessell, I.P. and Webster, M., 1994, Trends. Neurosci. 17: 149–150.
Davis, D.R., Brion, J., Gallo, J., Hanger, D.P., Ladhani, K., Lewis, C., Miller, C.C.J., Rupniak, T., Smith, C. and Anderton, B.H., 1995, Biochem. J. 309: 941–949.
Sadot, E., Gurwitz, D., Barg, J., Behar, L., Ginzburg, I. and Fisher, A., 1996, J. Neurochem. 66: 877–880.
Wisniewski, H.M., Constantinidis, J., Wegiel, J., Bobinski, M. and Tarnawski, M., 1994, Alzheimer. Dis. Assoc. Disord. 8: 211–221.
Nitsch, R.M., Slack, B.E., Wurtman, R.J. and Growdon, J.H., 1992, Science 258: 304–307.
Lee, R.K., Wurtman, R.J., Cox, A.J. and Nitsch, R.M., 1995, Proc. Natl. Acad. Sci. USA. 92: 8083–8087.
Clarke, N.A., Webster, M., Francis, P.T., Procter, A.W., Hodgkiss, A.D. and Bowen, D.M., 1993, Neurodegeneration 2: 243–248.
Schwartz, B.L., Hashtroudi, S., Herting, R.L., Handerson, H. and Deutsch, S.I., 1991, Neurology 41: 1341–1343.
Wesnes, K., Jones, R.W. and Kirby, J., 1991, Br. J. Clin. Pharmacol. 31: 577p–578p.
Mohr, E., Knott, V, Sampson, M., Wesnes, K., Herting, R. and Mendis, T., 1995, Clin. Neuropharmacol. 18: 28–38.
Madsen, U., Ebert, B. and Krogsgaard-Larsen, P., 1994, Biomed. Pharmacother. 48: 305–311.
Rickard, N.S. and Ng, K.T., 1995, Brain Res. Bull. 36: 355–359.
Pettit, H.O., Lutz, D., Gutierrex, C. and Eveleth, D., 1994, Neurosci. Lett. 178: 43–46.
Chessell, I.P, Francis, P.T., Webster, M., Procter, A.W., Heath, P.R., Pearson, R.C.A. and Bowen, D.M., 1994, J. Neural Transm. 44: 231–243.
Read, H.L., Beck, S.G. and Dun, N.J., 1994, Brain Res. 643: 17–28.
Dijk, S.N., Francis, P.T., Stratmann, G.C. and Bowen, D.M., 1995, Br. J. Pharmacol. 115: 1169–1174.
Dijk, S.N., Francis, P.T., Stratmann, G.C. and Bowen, D.M., 1995, J. Neurochem. 65: 2165–2169.
Mori, F., Lai, C.C., Fust, F. and Giacobini, E., 1995, NeuroReport 6: 633–636.
Dijk, S.N., Francis, P.T., Stratmann, G.C, Smith, M.A. and Bowen, D.M., 1994, Soc. Neurosci. Abs. 20: 1242( Abstract)
Nitsch, R.M., Farber, S.A., Growdon, J.H. and Wurtman, R.J., 1993, Proc. Nail. Acad. Sci. USA. 90: 5191–5193.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Francis, P.T., Dijk, S.N. (1997). Glutamatergic Function in Alzheimer’s Disease. In: Teelken, A., Korf, J. (eds) Neurochemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5405-9_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5405-9_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7468-8
Online ISBN: 978-1-4615-5405-9
eBook Packages: Springer Book Archive